Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 159

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part II, Item 3
Chunk 159
---
4
    
      us-gaap:PrivatePlacementMember

    2025-02-18

    0002028614

    2025-02-18
    2025-02-18

    0002028614
    
      us-gaap:IPOMember

    2025-02-18

    0002028614

    2025-02-18

    0002028614
    
      dmaau:SponsorMember

    2025-03-31

    0002028614
    
      dmaau:OrdinarySharesSubjectToPossibleRedemptionMember

    2025-01-29
    2025-01-29

    0002028614
    
      dmaau:OrdinarySharesSubjectToPossibleRedemptionMember

    2025-01-29

    0002028614
    
      dmaau:OrdinarySharesSubjectToPossibleRedemptionMember

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:OrdinarySharesSubjectToPossibleRedemptionMember

    2025-03-31

    0002028614
    
      us-gaap:OverAllotmentOptionMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:IPOMember

    2025-02-18
    2025-02-18

    0002028614
    
      dmaau:SponsorMember

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:SponsorMember
      dmaau:FounderSharesMember
      us-gaap:CommonStockMember

    2024-06-17
    2024-06-17

    0002028614
    
      dmaau:SponsorMember
      dmaau:FounderSharesMember
      us-gaap:CommonStockMember

    2024-06-17

    0002028614
    
      dmaau:SponsorMember
      dmaau:FounderSharesMember

    2024-11-06
    2024-11-06

    0002028614

      dmaau:SponsorMember
      dmaau:FounderSharesMember
      us-gaap